RMD.AX - ResMed Inc.

ASX - ASX Delayed Price. Currency in AUD
14.01
-0.15 (-1.06%)
As of 1:30PM AEDT. Market open.
Stock chart is not supported by your current browser
Previous Close14.16
Open13.99
Bid14.01 x 0
Ask14.02 x 0
Day's Range13.89 - 14.02
52 Week Range11.66 - 16.57
Volume1,010,209
Avg. Volume2,175,938
Market Cap20.036B
Beta (3Y Monthly)0.39
PE Ratio (TTM)44.92
EPS (TTM)0.31
Earnings DateN/A
Forward Dividend & Yield0.18 (1.32%)
Ex-Dividend Date2018-05-09
1y Target Est12.43
  • Markit12 days ago

    See what the IHS Markit Score report has to say about ResMed Inc.

    ResMed Inc NYSE:RMDView full report here! Summary * ETFs holding this stock have seen outflows over the last one-month * Bearish sentiment is low * Economic output for the sector is expanding but at a slower rate Bearish sentimentShort interest | PositiveShort interest is low for RMD with fewer than 5% of shares on loan. The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. Money flowETF/Index ownership | NegativeETF activity is negative. Over the last one-month, outflows of investor capital in ETFs holding RMD totaled $11.33 billion. Additionally, the rate of outflows appears to be accelerating. Economic sentimentPMI by IHS Markit | NegativeAccording to the latest IHS Markit Purchasing Managers' Index (PMI) data, output in the Healthcare sector is rising. The rate of growth is weak relative to the trend shown over the past year, however, and is easing. Credit worthinessCredit default swapCDS data is not available for this security.Please send all inquiries related to the report to score@ihsmarkit.com.Charts and report PDFs will only be available for 30 days after publishing.This document has been produced for information purposes only and is not to be relied upon or as construed as investment advice. To the fullest extent permitted by law, IHS Markit disclaims any responsibility or liability, whether in contract, tort (including, without limitation, negligence), equity or otherwise, for any loss or damage arising from any reliance on or the use of this material in any way. Please view the full legal disclaimer and methodology information on pages 2-3 of the full report.

  • GlobeNewswire20 days ago

    A New Era in Healthcare with Digital Health: Innovest Global Inc. (OTC: IVST), eWellness Healthcare, ResMed Inc. and Progressive Care Inc.

    Investorideas.com, a leading investor news resource covering technology and healthcare stocks releases a snapshot looking at how healthcare is changing in the digital age. Investorideas recently reported on how Digital Health technologies enabling out-of-hospital care and monitoring are forecast to grow by 30 percent and cross the $25 billion mark. In the article, Kamaljit Behera, Industry Analyst, Transformational Health, said, "In this highly digitized environment, artificial intelligence (AI) will permeate the life sciences ecosystem, and its use in healthcare IT (HIT) is likely to cross $1.7 billion by the end of 2019.

  • ResMed (RMD) Q2 2019 Earnings Conference Call Transcript
    Motley Fool25 days ago

    ResMed (RMD) Q2 2019 Earnings Conference Call Transcript

    RMD earnings call for the period ending December 31, 2018.

  • Barrons.com25 days ago

    The Dow Rises 184 Points Because the Fed Trumps the End of the Shutdown

    The Dow Jones Industrial Average rose 0.8% to close at 24,737.20 on a report that the Fed might stop winding down its bond holdings earlier than expected.

  • GuruFocus.com25 days ago

    3 Stocks Move Friday

    ResMed, Intuitive Surgical fall, OSI Systems rises

  • Associated Press25 days ago

    Western Digital, Starbucks rise while AbbVie, Intel drop

    Stocks that moved substantially or traded heavily Friday: Western Digital Corp., up $3.02 to $43.16 The hard-drive maker reported better-than-expected quarterly financial results and an upbeat forecast. ...

  • TheStreet.com25 days ago

    ResMed Tanks on Second-Quarter Revenue Miss

    The San Diego company reported a 9% increase in adjusted revenue to $651.1 million but lagged Wall Street's expectations of $667 million. "We had a solid quarter with top-line growth and gross margin expansion, as well as continued fiscal discipline to drive leverage and improved operating profit," said Mick Farrell, ResMed's CEO. Through the first half of the company's fiscal year, ResMed has posted an increase of 11% on adjusted revenue while earnings have gained 9%.

  • Acquisitions Cause ResMed's Profit Growth to Stall
    Motley Fool25 days ago

    Acquisitions Cause ResMed's Profit Growth to Stall

    Lavish spending on additions to the company's growing software business took a toll on net income.

  • Why ResMed Is Plunging Today
    Motley Fool25 days ago

    Why ResMed Is Plunging Today

    Disappointing quarterly results took a toll on the medical-device stock.

  • CNBC25 days ago

    Stocks making moves midday: Airlines, Ford, Western Digital, Vale & more

    These are the companies making headlines in the middle of Friday trading:Intel INTC , AMD AMD – Intel fell 5.5 percent after the chipmaker said it expects revenue to be nearly flat compared to last year.

  • Dow Jones Futures Pare Gains On Mueller Probe Arrest; Intel Leads 5 Top Stocks Moving
    Investor's Business Daily26 days ago

    Dow Jones Futures Pare Gains On Mueller Probe Arrest; Intel Leads 5 Top Stocks Moving

    Stone futures rose but pared gains on news that Trump adviser Roger Stone had been arrested. Intel fell on guidance. Starbucks rose on strong earnings.

  • Highly Rated Medtech Stock Topples On Mixed Earnings Report
    Investor's Business Daily26 days ago

    Highly Rated Medtech Stock Topples On Mixed Earnings Report

    ResMed stock crashed Thursday after the medical technology firm missed quarterly sales projections by $16 million. ResMed stock closed up a fraction.

  • Associated Press26 days ago

    ResMed: Fiscal 2Q Earnings Snapshot

    On a per-share basis, the San Diego-based company said it had net income of 86 cents. Earnings, adjusted for amortization costs and costs related to mergers and acquisitions, came to $1 per share. The ...

  • Business Wire26 days ago

    ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2019

    SAN DIEGO-- -- Year-over-year growth in revenue, gross margin, and operating profit Well-positioned for future growth through further penetration of untreated sleep apnea and expanding portfolio in respiratory care and Software as a Service Note: A webcast of ResMed’s conference call will be available at 4:30 p.m. EST today at http://investor.resmed.com ResMed Inc. , a world-leading connected health ...

  • GuruFocus.com28 days ago

    5 Companies Hit 52-Week Highs

    As of late, multiple companies have managed to reach yearly highs

  • ResMed’s First Top-of-Head CPAP Mask, AirFit N30i, Now Available across U.S.
    Business Wirelast month

    ResMed’s First Top-of-Head CPAP Mask, AirFit N30i, Now Available across U.S.

    ResMed (NYSE: RMD, ASX: RMD), today introduced AirFit N30i, its first top-of-head-connected nasal CPAP mask, across the United States, with a newly designed nasal cradle cushion that sits just under the wearer’s nose. The nasal cradle cushion – ResMed’s first – is designed to reduce facial markings and irritation. AirFit N30i is also convenient for equipment providers and sleep labs – it fits 96 percent of PAP users with just two frame sizes and four cushion sizes.

  • 3 Healthcare Stocks Hitting 52-Week Highs: Are They Buys?
    Motley Foollast month

    3 Healthcare Stocks Hitting 52-Week Highs: Are They Buys?

    Can the sizzling momentum continue for these high-flying healthcare stocks?

  • GlobeNewswirelast month

    New Research Coverage Highlights Gentex, Tenneco, Mercury General, MGM Resorts International, ResMed, and Alnylam Pharmaceuticals — Consolidated Revenues, Company Growth, and Expectations for 2019

    NEW YORK, Jan. 16, 2019 -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors,.

  • Mobi Is Here: ResMed’s First Portable Oxygen Device Now Widely Available in the U.S.
    Business Wirelast month

    Mobi Is Here: ResMed’s First Portable Oxygen Device Now Widely Available in the U.S.

    ResMed (NYSE: RMD, ASX: RMD), a leader in respiratory care medical devices and out-of-hospital care software, today announced that its premier portable oxygen concentrator, Mobi, is now widely available in the United States. Mobi offers an optimal balance of oxygen delivery, weight and battery life so that millions of people with chronic obstructive pulmonary disease (COPD) or other chronic diseases can enjoy ResMed-quality oxygen therapy wherever they go.

  • PR Newswirelast month

    Safeguard Scientifics Partner Company Propeller Health Acquired By ResMed

    RADNOR, Pa., Jan. 7, 2019 /PRNewswire/ -- Safeguard Scientifics, Inc. (SFE) (Safeguard or the Company) today announced that its partner company, Propeller Health, has been acquired by ResMed (RMD) (RMD.AX) for $225 million in cash. Safeguard will receive total cash proceeds of $41.4 million, which excludes an amount of additional proceeds to be held in escrow, representing an approximate 3x cash-on-cash return and 34% IRR. "The closing of the Propeller Health acquisition by ResMed brings together two exceptional teams dedicated to improving respiratory medicine with digital technology.

  • Business Wirelast month

    ResMed Completes $225 Million Acquisition of Propeller Health

    ResMed (RMD) (RMD.AX), a leader in cloud-connected medical devices and out-of-hospital software-as-a-service (SaaS) business solutions, today announced it has completed its acquisition of Propeller Health, a digital therapeutics company providing connected health solutions for people living with chronic obstructive pulmonary disease (COPD) and asthma. Propeller will continue to operate as a standalone business out of its Madison, Wisc., and San Francisco offices, working with leading pharmaceutical partners and other healthcare organizations to provide digital therapeutics and actionable insights to people who use inhalers, helping improve their medication adherence, increase their number of symptom-free days, and reduce emergency room visits.

  • Business Wire2 months ago

    ResMed to Report Second Quarter Fiscal 2019 Earnings on January 24, 2019

    ResMed today announced it plans to release financial and operational results for the second quarter of fiscal year 2019 on Thursday, January 24, 2019, after the New York Stock Exchange closes.

  • Stock Market Forecast For 2019: 7 Critical Trends To Watch
    Investor's Business Daily2 months ago

    Stock Market Forecast For 2019: 7 Critical Trends To Watch

    Is the stock market correction of the past three months a harbinger of an awful 2019, or a launchpad for a new bull market? While it's folly to make a stock market forecast for 2019, a few trends hold answers.